WallStreetZenWallStreetZen

NASDAQ: BCYC
Bicycle Therapeutics PLC Stock Ownership - Who owns Bicycle Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Bicycle Therapeutics PLC insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Michael Charles Ferguson HannayCHIEF PROD SUPPLY CHAIN OFF2024-04-11257$22.49
$5.78kSell
Travis Alvin ThompsonCHIEF ACCOUNTING OFFICER2024-04-03152$23.81
$3.62kSell
Nigel CrockettCHIEF BUSINESS OFFICER2024-04-03955$23.81
$22.74kSell
Nicholas KeenCHIEF SCIENTIFIC OFFICER2024-04-03790$23.81
$18.81kSell
Kevin LeeCHIEF EXECUTIVE OFFICER2024-04-033,158$23.81
$75.19kSell
Alistair MilnesCHIEF OPERATING OFFICER2024-04-03955$23.81
$22.74kSell
Michael SkynnerCHIEF TECHNOLOGY OFFICER2024-04-03955$23.81
$22.74kSell
Nicholas KeenChief Scientific Officer2024-01-032,640$17.50
$46.20kSell
Kevin LeeChief Executive Officer2024-01-038,703$17.50
$152.30kSell
Alistair MilnesChief Operating Officer2024-01-032,643$17.50
$46.25kSell

1 of 3

BCYC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BCYC insiders and whales buy or sell their stock.

BCYC Shareholders

What type of owners hold Bicycle Therapeutics PLC stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP15.14%6,449,320$151.24MInsider
Paradigm Biocapital Advisors LP8.70%3,707,001$86.93MInstitution
Deep Track Capital LP8.20%3,490,506$81.85MInstitution
Carolyn Ng4.69%1,998,580$46.87MInsider
Tybourne Capital Management Hk Ltd4.60%1,957,961$45.91MInsider
Jefferies Financial Group Inc4.57%1,948,000$45.68MInstitution
Deborah Harland4.50%1,915,275$44.91MInsider
Svlsf V LLC4.50%1,915,274$44.91MInsider
Glaxosmithkline PLC4.49%1,910,531$44.80MInsider
Kate Bingham4.49%1,910,016$44.79MInsider

1 of 3

BCYC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BCYC54.60%45.40%Net SellingNet Selling
MGNX72.54%27.46%Net BuyingNet Selling
INVA58.68%41.32%Net BuyingNet Buying
ABVX33.79%0.00%
MDXG42.42%57.58%Net BuyingNet Selling
View Top Biotech Stocks

Bicycle Therapeutics Stock Ownership FAQ

Who owns Bicycle Therapeutics?

Bicycle Therapeutics (NASDAQ: BCYC) is owned by 73.65% institutional shareholders, 61.24% Bicycle Therapeutics insiders, and 0.00% retail investors. Baker Bros Advisors LP is the largest individual Bicycle Therapeutics shareholder, owning 6.45M shares representing 15.14% of the company. Baker Bros Advisors LP's Bicycle Therapeutics shares are currently valued at $145.56M.

If you're new to stock investing, here's how to buy Bicycle Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.